| Literature DB >> 34103517 |
Silvia Stringhini1,2,3, María-Eugenia Zaballa4, Nick Pullen4, Carlos de Mestral4,5, Javier Perez-Saez6,7, Roxane Dumont4, Attilio Picazio4, Francesco Pennacchio4, Yaron Dibner4, Sabine Yerly8, Helene Baysson4,9, Nicolas Vuilleumier9,8,10, Jean-François Balavoine10, Delphine Bachmann11, Didier Trono12, Didier Pittet13, François Chappuis14, Omar Kherad15, Laurent Kaiser8,10,16, Andrew S Azman4,6,7, Idris Guessous9,14.
Abstract
Limited data exist on SARS-CoV-2 infection rates across sectors and occupations, hindering our ability to make rational policy, including vaccination prioritization, to protect workers and limit SARS-CoV-2 spread. Here, we present results from our SEROCoV-WORK + study, a serosurvey of workers recruited after the first wave of the COVID-19 pandemic in Geneva, Switzerland. We tested workers (May 18-September 18, 2020) from 16 sectors and 32 occupations for anti-SARS-CoV-2 IgG antibodies. Of 10,513 participants, 1026 (9.8%) tested positive. The seropositivity rate ranged from 4.2% in the media sector to 14.3% in the nursing home sector. We found considerable within-sector variability: nursing home (0%-31.4%), homecare (3.9%-12.6%), healthcare (0%-23.5%), public administration (2.6%-24.6%), and public security (0%-16.7%). Seropositivity rates also varied across occupations, from 15.0% among kitchen staff and 14.4% among nurses, to 5.4% among domestic care workers and 2.8% among journalists. Our findings show that seropositivity rates varied widely across sectors, between facilities within sectors, and across occupations, reflecting a higher exposure in certain sectors and occupations.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34103517 PMCID: PMC8187639 DOI: 10.1038/s41467-021-23796-4
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Sample description and prevalence of anti-SARS-CoV-2 IgG antibodies, SEROCoV-WORK + study, May–September 2020, Geneva, Switzerland.
| Seropositive | Relative risk (95% CrI) | ||
|---|---|---|---|
| Total | 10513 | 1026 (9.8) | – |
| Women | 5848 (55.6) | 598 (10.2) | 1.00 (ref.) |
| Men | 4665 (44.4) | 428 (9.2) | 0.88 (0.76–1.01) |
| Age group, years | |||
| 18–34 | 2678 (25.5) | 291 (10.9) | 1.00 (ref.) |
| 35–49 | 4524 (43.0) | 467 (10.3) | 0.94 (0.80–1.10) |
| 50–65 | 3311 (31.5) | 268 (8.1) | 0.71 (0.57–0.85) |
| Educational levela | |||
| Mandatory education | 867 (8.3) | 87 (10.0) | 0.75 (0.50–1.07) |
| Apprenticeship | 2216 (21.1) | 175 (9.7) | 0.54 (0.35–0.76) |
| Secondary education | 2098 (20.0) | 194 (9.3) | 0.65 (0.45–0.90) |
| University | 4626 (44.0) | 491 (10.6) | 0.77 (0.56–1.04) |
| Doctorate | 413 (3.9) | 52 (12.6) | 1.00 (ref.) |
| Other | 289 (2.7) | 27 (9.3) | – |
| Activity sectorb | |||
| Healthcare | 1668 (15.9) | 185 (11.1) | 1.00 (ref.) |
| Transportation | 1185 (11.3) | 99 (8.4) | 0.66 (0.31–1.18) |
| Nursing homes | 1102 (10.5) | 157 (14.3) | 1.24 (0.67–2.07) |
| Public administration | 1056 (10.0) | 94 (8.9) | 0.91 (0.41–1.74) |
| Public security | 1055 (10.0) | 83 (7.9) | 0.53 (0.22–0.93) |
| Food industry | 755 (7.2) | 76 (10.1) | 0.92 (0.46–1.67) |
| Homecare | 753 (7.2) | 91 (12.1) | 0.99 (0.33–2.06) |
| Social work | 734 (7.0) | 62 (8.5) | 0.68 (0.27–1.33) |
| Financial services | 528 (5.0) | 65 (12.3) | 1.00 (0.42–1.93) |
| International organizations | 425 (4.0) | 24 (5.7) | 0.47 (0.10–1.40) |
| Early childhood education | 259 (2.5) | 15 (5.8) | 0.37 (0.09–0.84) |
| Pharmacy | 254 (2.4) | 28 (11.0) | 0.86 (0.37–1.58) |
| Construction | 182 (1.7) | 11 (6.0) | 0.53 (0.10–1.52) |
| Media | 166 (1.6) | 7 (4.2) | 0.55 (0.07–2.02) |
| Agriculture | 97 (0.9) | 8 (8.3) | 0.65 (0.13–1.70) |
| Other | 294 (2.8) | 21 (7.1) | 0.54 (0.17–1.08) |
| Confinement statusc | |||
| Mobilized/partially confined | 9430 (89.9) | 899 (9.5) | 1.00 (ref.) |
| Fully confined | 1065 (10.1) | 125 (11.7) | 1.27 (1.03–1.56) |
| Out-of-work exposured | |||
| 0 | 9129 (87.0) | 775 (8.5) | 1.00 (ref.) |
| ≥1 | 1365 (13.0) | 248 (18.2) | 2.29 (1.93–2.74) |
| Smoking | |||
| Non-smoker | 6122 (58.3) | 709 (11.6) | 1.00 (ref.) |
| Ex-smoker | 1664 (15.8) | 143 (8.6) | 0.72 (0.55–0.88) |
| Smoker | 2718 (25.9) | 172 (6.3) | 0.45 (0.30–0.57) |
| BMI group | |||
| 18–24.9 | 5747 (56.1) | 585 (10.2) | 1.00 (ref.) |
| 25–29.9 | 3278 (32.0) | 306 (9.3) | 0.96 (0.81–1.13) |
| ≥30 | 1227 (12.0) | 115 (9.4) | 0.96 (0.75–1.19) |
| Chronic conditionse | |||
| None | 9282 (88.3) | 903 (9.7) | 1.00 (ref.) |
| 1 | 1062 (10.1) | 106 (10.0) | 1.11 (0.87–1.38) |
| ≥2 | 167 (1.6) | 17 (10.2) | 1.19 (0.62–1.89) |
Results are N (%), or as stated. Relative risks (95% credible interval) are from Bayesian logistic regression models, and are adjusted for test performance, age and sex. These pertain to the reference individual (Female, 18–34). 69 participants were excluded due to missing serology or sociodemographic data, or due to being outside target age range of 18–65 years. All data beside serology are self-reported.
aEach category indicates the highest level of education attained by participant; mandatory education indicates 15 years of primary education as the highest obtained degree.
bSee Supplementary Table 1 for details.
cFully confined at home between March and May 2020; otherwise partially confined or fully mobilized at work.
dOut-of-work exposure to confirmed COVID-19 cases.
eChronic conditions: hypertension, diabetes, cardiovascular disease, respiratory disease, cancer.
Fig. 1Prevalence of anti-SARS-CoV-2 IgG antibodies by activity sector, SEROCoV-WORK + study, May–September 2020, Geneva, Switzerland.
Sample size: 10,513 participants, 1026 of which were seropositive. Blue dots represent proportion of seropositive participants per company/workplace facility. Dot size indicates number of employees participating. Darker dots indicate more than one facility with same or very similar seropositivity rate. Vertical orange bar and yellow area indicate general working-age population seropositivity rate and 95% binomial confidence interval, respectively, from SEROCoV-POP study[20,21]. Small gray vertical bars show the proportion positive of all participants per sector. Facilities with <10 participants are not shown as dots, but these participants are included in the sector average.
Fig. 2Prevalence of anti-SARS-CoV-2 IgG antibodies by occupation, SEROCoV-WORK + study, May–September 2020, Geneva, Switzerland.
Sample size: 10,513 participants, 1026 of which were seropositive. Red dots indicate mean seropositivity rate for each occupation, while horizontal gray lines represent 95% binomial confidence intervals. Dot size indicates number of employees with that occupation. Vertical orange bar and yellow area indicate general working-age population seropositivity rate and 95% binomial confidence interval, respectively, from SEROCoV-POP study[20,21].